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Cryptococcus neoformans is an AIDS-associated human
fungal pathogen that often causes lung and brain infec-
tion and is the leading cause of fungal meningitis in
immunocompromised persons. The underlying mech-
anism of disease development in the brain that leads to
cryptococcal brain infection remains incompletely
understood. Our previous studies have demonstrated
that importers of sugar compound inositol (ITR) are
required for Cryptococcus virulence. Animal studies
using a cryptococcal strain lacking two major ITRs
(itr1aΔ itr3cΔ) demonstrated that ITRs are required
for full virulence during the brain infection, despite the
normal in vivo growth of the mutant strain in the
infected mouse brains. To understand the immune
pathology associated with the virulence reduction of
the itr1aΔ itr3cΔ mutant, we investigated the host re-
sponse during mouse brain infection by examining the
host gene expression profile using next generation se-
quencing techniques. Our study shows that compared
to the wild type, infection of mouse brains by the mu-
tant strain leads to significant up-regulation of many
host genes involved in host protective immune re-
sponse. Interestingly, a significant reduction in poly-
saccharide secretion was observed in the mutant cells,
indicating inositol utilization plays a role in cell surface
capsule production. Because capsule has been shown
to play a role in the host response during Cryptococ-
cus-host interactions, our results suggest that the in-
creased immune activation in the mutant-infected
animals may be due to the reduced polysaccharide se-
cretion that leads to virulence attenuation.
Background
Cryptococcus neoformans is a fungal pathogen that fre-
quently infects the central nervous system (CNS) to
cause life-threatening meningoencephalitis. Cryptococ-
cosis accounts for over 620,000 death annually world-
wide [1]. The molecular basis of cryptococcal infection
of the CNS is an area of intensive investigation. Multiple
fungal and host factors have been identified to play a
role in the fungal penetration of the blood brain barrier
(BBB) and to cause CNS infection [2-5]. The polysac-
charide capsule of C. neoformans is a major virulence
factor that is associated with the outcome following
initial pathogen-host interaction, including BBB cross-
ing and establishing CNS infection [6-8]. In addition,
mutagenesis studies have shown that cryptococcal ure-
ase and inositol transporters (ITR) are required for the
full virulence as evidenced by the defect of these mu-
tants in penetrating the BBB and causing CNS infection
[2,9-11]. Screening for mutants with attenuated viru-
lence yielded multiple genes that are required for
the survival of Cryptococcus in the cerebrospinal fluid(CSF), including an ubiquitin-like protein (Rub1) and
the phosphatidylinositol-4-kinase (Pik1) [12]. The Rub1
protein is also related to fungal transmigration into the
CNS; mutant possessing a null mutation in the putative
Rub1 gene exhibited increased transmigration into the
brain [13]. Recently, using a spectral counting method,
expression of a broad range of host cell proteins in-
volved in cytoskeleton rearrangement, cellular metabol-
ism, intracellular signaling and inflammation were
identified to be up-regulated during penetration of the
BBB by C. neoformans [14]. Despite these findings, the
underlying mechanism of frequent CNS cryptococcosis
and the host immune responses during cryptococcal in-
fection remains incompletely understood.
Recently, we have shown that Cryptococcus contains
an unusually large ITR gene family [15,16]. Based on
our studies on two major ITR, Itr1a and Itr3c, we
found that ITRs are required for full virulence of Cryp-
tococcus, particularly during the fungal penetration of
the BBB to cause infection of the CNS [9]. In accord-
ance with the importance of fungal ITRs, human and
animal brains contain high inositol levels. Thus, the
ability of Cryptococcus to efficiently acquire and utilize
host inositol could be associated with the high rate of
CNS cryptococcosis. Transcriptome analysis of Crypto-
coccus cells directly isolated from AIDS patients with
cryptococccal meningitis also showed up-regulation of
ITRs during brain infection [17]. In addition, using a
murine intra-cerebral infection model, we have shown
that mice infected by the itr1aΔ itr3cΔ mutant survive
significantly longer, compared to those infected by the
wild type [18]. However, in vivo growth assays in both
murine and rabbit CNS showed that the mutant and
wild type Cryptococcus had similar growth rates, sug-
gesting that the mutant had normal growth in the
brain [9]. Therefore, it remains unknown what caused
the virulence attenuation of the itr1aΔ itr3cΔ mutant
strain.
In this study, we tested the hypothesis that during
murine brain infection, the differential host response
elicited in the mouse brain infected by the wild type
and the itr1aΔ itr3cΔ mutant strains leads to a differ-
ence in disease outcome. We interrogated the host
response during brain infection using genome-wide
transcriptional analysis by shotgun RNA-Seq technol-
ogy. Our results show that compared to the wild type,
infection with the itr1aΔ itr3cΔ mutant led to signifi-
cantly up-regulation of genes involved in the host pro-
tective immune response in the infected mouse brain.
In addition, activation of host destructive networks,
such as cell death, which can contribute to exacerbated
inflammation and tissue destruction, was noted only in
the wild type-infected, compared to mutant-infected
mouse brains. We further showed that the altered
Figure 1 Summary of genome-wide transcriptome analysis of
the wild type or itr1aΔ itr3cΔ mutant infected mouse brain. (A)
Venn diagram showing the number of total and common SDEG
dysregulated in the brain of mouse infected with the wild type
H99 (red circle) or the itr1aΔ itr3cΔ mutant (blue circle). (B)
Intensity plot of the SDEG from the wild type (H99)-infected,
relative to the uninfected, animals. (C) Intensity plot of all the
SDEG from the mutant-infected, relative to the uninfected, animals.
The plots were drawn with descending level of gene expression
(top to bottom). The scale bar ranges from +3 (red) to −3(blue)
and is common to both (B) and (C). The RNA-seq data was
obtained from 3 mouse per group and analyzed group-wise by
one-way ANOVA (n = 3/group).
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tential causal link for the altered host immune re-
sponses. Thus, our study highlights the molecular
immunologic correlates of host response against Cryp-
tococcus infection, and revealed a potential mechanis-
tic explanation for the role of fungal inositol utilization
in the establishment of CNS cryptococcosis.
Results
Genome-wide transcriptome of mouse brains infected
with wild type or the itr1aΔ itr3cΔ double mutant
Cryptococcus
To test the hypothesis that the virulence attenuation of the
itr1aΔ itr3cΔ double mutant during mouse brain infection
is associated with its ability to elicit different host immune
response, we analyzed the genome-wide transcriptome of
the mouse brain after infection with either the wild type
or the itr1aΔ itr3cΔ mutant, using RNA-Seq method.
More than 343 Mbp of RNA-Seq data was generated
for each wild type - and itr1aΔ itr3cΔ mutant-infected
samples that contain over 7 million reads. The rates of
assembled reads in all samples were over 99.1% that
covered about 90% of the genome (Additional file 1:
Table S1).
The mapped and annotated RNA-Seq reads were
used as input in the Partek Genomics Suite to identify
significantly differentially expressed genes (SDEG). We
applied a false discovery rate (FDR) of 5% (q value ≤
0.05) as cut-off to select the SDEG from the raw data-
set (Figure 1). The density of RNA-Seq reads, taken as
equivalent of gene expression, from the wild type- or
mutant-infected mouse brain were normalized to the
uninfected counterparts. Using this approach, we have
identified SDEG that are independently regulated in
the wild type or mutant-infected, relative to uninfected
mouse brain. Then we compared the differentially
expressed genes between wild type- and mutant-
infected mouse brains. Using a 5% FDR cut-off, we
found 2,713 SDEG (1,113 genes up-regulated; 1,600
genes down-regulated) in the wild type-infected, rela-
tive to the uninfected, mouse brain (Figure 1A). In the
itr1aΔ itr3cΔ mutant-infected mouse brain, we have
identified 830 SDEG (552 genes up-regulated; 278
genes down-regulated). Of the 552 up-regulated genes,
more than 55% were expressed by greater than 2 fold;
while only 22 of the 278 SDEG were down-regulated
by 2 fold or more. In contrast, about 12% of SDEG
were up-regulated and 13% were down-regulated in
the wild type-infected mouse brain (Figure 1B and C).
In addition, there were 371 SDEG commonly expressed
between the wild type- and mutant -infected brains. In
summary, among the total number of SDEG, the ex-
pression of about 41% was up-regulated and 59% were
down-regulated in the wild type-infected mouse brain;
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33% were down-regulated in the mutant-infected
mouse brain. Thus, despite of more than 3-fold in-
crease in the total number of SDEG in the wild type-,
compared to mutant-infected mouse brain, the per-
centage of up-regulated genes was greater in the later
samples.Gene ontology analysis of SDEG
To determine the host biological functions perturbed
by the SDEG, we performed gene ontology (GO) ana-
lysis using Ingenuity Pathway Analysis (IPA) software
with the list of SDEG generated (FDR ≤ 5%) during
wild type or mutant infection of mouse brain. The
most significantly affected host biological functions
were sorted based on the p-value significance. As
shown in Table 1, the top biological functions that are
significantly affected includes neurological disease,
host cell death and survival, cellular growth, prolifera-
tion and migration, host immune response, cell-cell
interaction, nervous system development and function,
gene expression, cell movement as well as cell signal-
ing. To understand whether these biological functions
were impacted positively (activation) or negatively
(inhibition) by the expression pattern of SDEG, we
used a z-score algorithm-based prediction from IPA.
The z-score algorithm predicts the role of a gene in
positively or negatively affecting a biological function
based on its expression pattern, relative to the direc-
tion and pattern of expression of all member genes thatTable 1 Ontology analysis of SDEG in mouse brain infected b
Wild type
No. Category p value (range)
1 Neurological Disease 5.56E-61-6.96E-05
2 Cell Death and Survival 7.57E-30-1.19E-04
3 Cell-To-Cell Interaction 1.69E-28-1.02E-04
4 Nervous System Development and Function 1.69E-28-7.79E-05
5 Cellular Growth and Proliferation 2.12E-22-1.02E-04
6 Gene Expression 3.8E-19-7E-05
7 Cellular Movement 1.96E-09-1.2E-04
8 Cell Signaling 8.74E-05-8.74E-05
9 Cell-mediated Immune Response ns
10 Humoral Immune Response ns
11 Inflammatory Response ns
12 Immune Cell Trafficking ns
13 Antimicrobial Response ns
14 Free Radical Scavenging ns
ns-not statistically significant.constitute a biological function. Accordingly, among
the biological functions commonly shared between the
wild type and mutant infections, a significant activa-
tion (z-score ≥ 2) in the host cell destruction processes,
such as cell death and necrosis, was noted only in the
wild type-infected mouse brain. These biological func-
tions were not significantly activated in the mutant-
infected brain; in contrast, many SDEG involved in
the host protective responses were activated only in
the mutant-infected mouse brain. Specifically, the expres-
sion pattern of SDEG in these animals was consistent with
the activation of proinflammatory response, immune cell
trafficking and antimicrobial response, as well as free rad-
ical scavenging (Table 1). Taken together, the GO analysis
of differential gene expression patterns suggests that ac-
tivation of biological processes that are detrimental to
the host during wild type infection may promote infec-
tion and progressive disease pathology. On the other
hand, activation of host-protective biological functions
associated with reduced inflammation could contribute
to effective control of infection and lethality in the
mutant-infected animals.
Cellular networks associated with host destructive
functions are activated in the wild type Cryptococcus
infected mouse brain
Since the GO analysis of SDEG revealed striking differ-
ences in the neurological disease and associated cellular
functions between the wild type- and mutant-infected
mouse brains, we investigated the expression patterns of
specific network genes involved in these biologicaly wild type or Itr1aΔ itr3cΔ mutant cells
Itr1aΔ itr3cΔ
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in neurological disease network (Figure 2A, 2C and
Additional file 2: Table S2). These network genes code
for G protein-coupled receptors (9 genes), enzymes
(139 genes), including peptidases, kinases and phos-
phatases, transcriptional regulators (56 genes), trans-
membrane receptors (15 genes) and transporters (49
genes) (Additional file 2: Table S2). Of these SDEG,
215 were up-regulated and 237 were down-regulated
by more than 2-fold in mouse brain infected with the
wild type. However, expression of 58 SDEG was up-
regulated and 50 were down-regulated in the mutant-
infected mouse brain. Similarly, a subset of 107 SDEG
was involved in the cell death network (Figure 2B, 2D
and Additional file 2: Table S2). Most of these genes’
products are localized to the cytoplasm (46 genes),
while others are localized to the nucleus, plasma
membrane or secreted to extracellular space. Of these
SDEG, 52 were up-regulated and 43 were down-
regulated during wild type infection. These numbers
reduced to 25 and 13, respectively, in the mutant-infected
animals. In addition, a subset of 69 genes out of 107 was
significantly expressed only in the wild type, compared to
12 genes in the mutant-infected animals. Thus, consistent
with ontology analysis, a higher number of SDEG involved
in the neurological disease and cell death network were up-
and down-regulated in the wild type-infected, relative to
the mutant-infected, mice brains. Moreover, the expression
pattern of these network genes suggests activation of the
neurological disease and cell death only in the wild type-
infected mouse brain.
Cellular networks associated with host protective immune
response are activated in the itr1aΔ itr3cΔ double mutant
infected mouse brain
In general, host response triggered during infection and/
or injury leads to restriction of damage to the targeted
host and/or prevention/recovery from the injury caused
by the attack. To determine the host response to infection
by wild type or mutant Cryptococcus, we interrogated the
respective SDEG for their expression pattern and selective
role in cell viability and survival, proinflammatory re-
sponse, and cell-mediated immune response networks
(Figure 3 and Additional file 3: Table S3). A subset of 170
SDEG was involved in cell viability and survival network.
These genes encode for cytokines (12 genes), enzymes (51
genes), transcriptional regulators (21 genes), transmem-
brane receptors (23 genes) and transporters (12 genes). Of
these SDEG, expression of more than 67% (115 genes)
was up-regulated and 55 genes were down-regulated in
the mutant- infected mouse brain. (Figure 3A, 3D and
Additional file 3: Table S3). In contrast, expression of 45
SDEG was up- and 37 were down-regulated in the wild
type-infected mouse brain.Similarly, of the 174 SDEG involved in the proinflam-
matory response network, only 51 were up-regulated in
the wild type-infected mouse brains, compared to 135
SDEG in the mutant- infected ones (Figure 3B, 3E and
Additional file 3: Table S3). In addition, of the 174
SDEG, expression of 24 were down-regulated in the wild
type-infected and 39 were down-regulated in the
mutant-infected mouse brain, respectively, while other
99 SDEG showed similar expression levels in mice in-
fected by either wild type or the mutant.
The cell-mediated immune response network com-
prised of a subset of 102 SDEG (Figure 3C, 3F and
Additional file 3: Table S3) that encode for cytokines (12
genes), enzymes (17 genes), transcriptional regulators
(24) and transmembrane receptors (25 genes). Among
these, expression of 83 was up-regulated and 19 were
down-regulated in the mutant-infected mouse brain. In
contrast, 28 SDEG were up-regulated and 13 were
down-regulated in the wild type-infected mouse brain.
Taken together, both the number of SDEG and their
expression pattern suggests significant activation of cell
viability and survival, proinflammatory response as well
as cell-mediated immune response networks/pathways,
predominantly in the mutant-infected, compared to the
wild type-infected, mouse brain.
Differential regulation of IFN-γ and TNF-α network in
mouse brains infected by the wild type or itr1aΔ itr3cΔ
double mutant
To understand the molecular correlates of differential
pathogenesis between the wild type- and mutant- in-
fected mouse brains, we analyzed the expression pattern
of SDEG regulated by IFN-γ and TNF-α, two key cyto-
kines that are crucial for the host defense against micro-
bial infection (Figure 4 and Additional file 4: Table S4).
There were 715 SDEG in the IFN-γ regulon that en-
codes for cytokines (21 genes), enzymes (195 genes),
transcriptional regulators (69 genes), transmembrane re-
ceptors (69 genes) and transporters (49 genes). Of these
SDEG, 472 (66%) were up-regulated and 243 (34%) were
down-regulated, in the mouse brain infected by the mu-
tant. In contrast, the number of up- and down-regulated
SDEG decreased to 182 (25.5%) and 140 (19.5%), respect-
ively, in the wild type-infected mouse brain (Figure 4A).
Of the 173 SDEG regulated by TNF-α, expression of
96 genes were up-regulated and 19 genes were down-
regulated in the mutant-infected animals. In contrast, 59
SDEG were up-regulated and 42 were down-regulated in
the wild type-infected mouse brain (Figure 4B). Thus,
both the number of SDEG involved in the IFN-γ and/or
TNF-α regulon and their expression pattern suggest sig-
nificant activation of the host protective immune net-
works/pathways in the mutant-infected, compared to the
wild type-infected, mouse brain.
Figure 2 Expression profile of neurological disease and cell death network genes. (A) Intensity plot of SDEG (452 genes) involved in
neurological disease network in the wild type H99- or the itr1aΔ itr3cΔ mutant-infected mouse brain. A subset of 15 most highly differentially expressed
genes in this network is listed in (C). (B) Intensity plot of SDEG (107 genes) involved in cell death network in the wild type- or mutant-infected animals.
A subset of 15 most highly differentially expressed genes in this network is listed in (D). The intensity plots were drawn with descending level of gene
expression sorted in the wild type-infected samples (top to bottom). The scale bar ranges from +2 (red) to −2 (blue) and is common to all panels.
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Figure 3 Expression profile of cell viability and survival, proinflammatory response and cell mediated immune response network
genes. (A) Intensity plot of SDEG (170 genes) involved in cell viability and survival network in the wild type- or mutant-infected animals. A subset
of 15 most highly differentially expressed genes in this network is listed in (D). (B) Intensity plot of SDEG (174 genes) involved in proinflammatory
response network in the wild type- or mutant-infected animals. A subset of 15 most highly differentially expressed genes in this network is listed
in (E). (C) Intensity plot of SDEG (102 genes) involved in cell mediated immune response network in the wild type- or mutant-infected animals. A
subset of 15 most highly differentially expressed genes in this network is listed in (F). The plots were drawn with descending level of gene
expression sorted in the mutant-infected samples (top to bottom). The scale bar ranges from +2 (red) to −2 (blue) and is common to all panels.
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canonical IFN signaling pathway in the mouse brain
infected by the itr1aΔ itr3cΔ double mutant
We next interrogated the SDEG for their involvement in
the host protective, Th1 response network and canonicalinterferon (IFN) signaling pathway (Figure 5). Of the 20
SDEG that are part of the Th1 response network, only
four each were up- and down-regulated, respectively, in
the wild type-infected mouse brains (Figure 5A). In con-
trast, in the mutant-infected mouse brains, 14 out of 20
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Cxcl10, Stat3, Irf1, Ccr5 and Ccr1 were significantly up-
regulated, (Figure 5B). Similarly, expression of several
genes in the canonical IFN signaling pathway, including
Ifng, Jak2, Stat1, Stat2, Socs1, Irf1, Irf9, Tap1, Ifitm1,
Psmb8, Ifi35, Gas1 and Fit3 were up-regulated during in-
fection by the mutant strain (Figure 5C). In contrast, ex-
pression of only three genes (Stat1, Tap1 and Psmb8)
was up-regulated and Bcl2 was down-regulated in the
wild type-infected animals. Taken together, both the
number of up-regulated SDEG and their level of expres-
sion in the Th1 response network, as well as IFN signal-
ing pathway suggest activation of host protective
immune response during infection by the mutant-, com-
pared to the wild type-infected mouse brain.
Activation of alternate complement activation pathway in
mouse brain infected by the itr1aΔ itr3cΔ double mutant
Finally, we examined the SDEG to decipher the
complement-mediated innate immune response network
in the infected mouse brains. Complement activation
pathways play crucial role during cryptococcal infection.
While complement components, such as C1 (q, r, s),
C2a and C4 (a, b) are classified as classical activation
pathway, C3 (a, b) and BF (a, b) are considered as mem-
bers of the alternate activation pathway (Figure 6).
Among the SDEG that code for classical pathway, C1q,
C4a and C4b were significantly up-regulated both in the
wild type and mutant-infected animals (Figure 6A and
6B). However, SDEGs that encode other members of the
classical pathway (C1r, C1s and SerpinG1) were up-
regulated only in the mutant-infected mouse brain
(Figure 6B). Surprisingly, the SDEG involved in the alter-
nate pathway (C3a, C3b, Bfa, Bfb and Hf1) were signifi-
cantly up-regulated in the mutant-infected mouse brain;
these genes were not significantly affected during wild
type-infection (Figure 6A and 6B). In summary, while
most genes in the classical complement activation path-
way were up-regulated in wild type as well as mutant-
infected animals, selected genes in the alternate pathway
are predominantly up-regulated in the later, suggesting
an efficient innate, complement-mediated protection of
the host during infection by this mutant strain.
Validation of RNA-Seq by qRT-PCR analysis
To confirm and validate the level and pattern of gene
expression observed in our RNA-Seq analysis, we per-
formed qRT-PCR analysis. We selected 15 genes ran-
domly to avoid selection-bias and used the same total
RNA from RNA-seq experiments as templates for the
qRT-PCR. Consistent with the RNA-seq results, expres-
sion of Cxcl10, Ifng, Il6, Il1b, Il1α, Ccl2, Arg1, Saa3 and
Ccl8 were up-regulated and Psap was down-regulated in
the mutant-infected, compared to the wild type-infectedmouse brain (Figure 7). Taken together, the pattern and
extent of gene expression determined by qRT-PCR ana-
lysis is consistent with the RNA-Seq analysis, thus con-
firming the consensus between these two methodologies
and validating our RNA-Seq-based gene expression
analysis.
The itr1aΔ itr3cΔ double mutant is defective in cell
surface structure
Based on our previous study, we hypothesized that the
difference in fungal cell surface structure between the
wild type and itr1aΔ itr3cΔ mutant could contribute to
the differential host response in the infected mouse
brains. We have shown [9] that the itr1aΔ itr3cΔ double
mutant had reduced production of hyaluronic acid
(HA), a ligand required for fungal cell interaction with
endothelial cell during BBB crossing [19,20]. In addition,
Cryptococcus can use inositol as a sole carbon source, in
which condition, fungal cells remain encapsulated. This
phenomenon indicates that inositol may be utilized to
regulate capsule production, especially under the condi-
tions with abundant inositol, such as inside the brain.
To test the hypothesis that inositol is required for cap-
sule formation and that mutation of two major fungal
inositol transporters (Itr1a and Itr3c) may result in an al-
tered capsule structure, we measured capsule size and
GXM secretion in the wild type and itr1aΔ itr3cΔ mutant
under conditions with different inositol levels. Our results
showed that both wild type and mutant cells produced sig-
nificantly larger capsule (P < 0.0001) when they were cul-
tured on medium with inositol as a carbon source than on
medium with glucose as a carbon source (Figure 8A). There
was no significant difference observed in the capsule sizes
between wild type and mutant cells when grown on either
glucose or inositol medium (Figure 8A). In addition, though
the capsule size of mutant strains, as measured in the Gro-
cott Methenamine Silver-stained sections of infected mouse
brain, was smaller than the wild type counterpart, the dif-
ference was not statistically significant (Additional file 5:
Figure S1). However, the secretion of GXM was signifi-
cantly reduced when fungal cells were grown in vitro on in-
ositol medium (P < 0.0001). In addition, the GXM secretion
by the mutant strain was significantly reduced, compared
to the wild type, when inositol was used as a sole carbon
source (P < 0.0005) (Figure 8B).
Taken together, our data suggest that activation of the
host protective response in mouse brains infected by the
itr1aΔ itr3cΔ double mutant is associated with its defect
in inositol utilization, which may contribute to the
in vivo alteration of either the capsule structure or GXM
secretion or both. However, the potential role of add-
itional factors, including the alteration of HA production
and phospholipids observed in the mutant strain [9], re-
mains to be determined in vivo.
Figure 4 Expression of genes regulated by IFN-γ and TNF-α. (A)
Intensity plot of SDEG (715 genes) regulated by IFN-γ in the wild
type - or the itr1aΔ itr3cΔ mutant-infected animals. (B) Intensity plot
of SDEG (173 genes) regulated by TNF-α in the wild type- or
mutant-infected animals. The scale bar ranging from +2 (red) to −2
(blue) in both (A) and (B).
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mutant infected mouse brain
To determine the extent of disease pathology elicited by
the wild type and mutant strain, we performedimmunohistologic staining on the infected mouse brain
using antibodies against GXM (a marker for C. neofor-
mans), GFAP (an astrocyte marker) or Iba1 (a macro-
phage/microglia marker). The stained sections were
analyzed by confocal microscopy and the images were
subsequently reconstructed in x, y and z axis (3D recon-
struction) (Figure 9). Consistent with our in vitro meas-
urement data (Figure 8), the confocal imaging results
showed less GXM staining around the brain lesions in-
fected by the itr1aΔ itr3cΔ mutant strain. The brain le-
sions from wild type-infected mouse had GFAP-positive
astrocytes surrounding the fungus inside (Figure 9).
Though the mutant-infected brain sections had lesions with
the fungus inside, it was not well contained; the GFAP
positive cells were not tightly surrounding the lesion,
rather they were found diffused. In these samples,
more GFAP signal was detected at sites distal to the le-
sion. Similar results of fungal localization and micro-
glial cell activation were observed in the Iba1 stained
brain sections (Figure 9). Taken together, infection of
mouse brain by the mutant strain caused a more wide
spread activation of astrocytes and microglial cells,
which is consistent with our transcriptome data.
Discussion
Cryptococcosis has emerged as a major fungal infection,
mainly due to the increase in population with immune
deficiencies caused, for example, by the epidemic of
HIV/AIDS and increased use of immunosuppressive
drugs. The complex host response to cryptococcal infec-
tion involves innate cellular and humoral immune re-
sponses as well as cell-mediated adaptive immune
responses [21-23]. The antifungal activity of alveolar
macrophages as the first line of host defense mechanism
against cryptococcal infection has been a subject of inten-
sive investigation [24-26]. Similarly, the relative roles of
complement components, surfactant molecules and innate
cellular responses during Cryptococcus-host cell interaction
have been described earlier [21,22]. Moreover, the import-
ance of CD4+ and CD8+ Tcells in eliciting host immune re-
sponse during fungal infections are well recognized. These
studies, as well as several others on the role of various cyto-
kines and their expression profiles during cryptococcal in-
fection, have consistently showed that a protective immune
response is closely associated with a robust Th1-type im-
munity [27,28].
We have recently shown that interaction between the
fungal inositol transporters and the host inositol is re-
quired for the development of cryptococcosis in murine
models. Despite the fact that mice infected by wild type
and the itr1aΔ itr3cΔ double mutant showed similar
in vivo growth rates in brain, a delayed killing of those
infected by the mutant, compared to the wild type, was
observed in a mouse intracerebral infection model [9].
Figure 5 Expression of genes in the Th1 response network and interferon signaling pathway. (A) Interaction and expression of Th1
response genes in the wild type H99-infected animals. (B) Interaction and expression of Th1 response genes in the itr1aΔ itr3cΔ mutant-infected
animals. (C) Interaction and expression of canonical interferon signaling pathway genes in the mutant-infected animals. Shapes in red are
up-regulated and green are down-regulated. Intensity of the shape colors is relative to the level of gene expression (dark color denotes stronger
expression). Solid lines represent direct interaction and broken lines show indirect interactions. The legend is common for (A), (B) and (C).
Liu et al. Cell Communication and Signaling 2014, 12:51 Page 10 of 17
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mutant strain may trigger different and/or increased
protective host immune responses. Consistently, ourdata showed a clear pattern of greater activation of pro-
tective immune response during infection by the mutant,
compared to wild type strain. Moreover, dampening of the
Figure 6 Expression of genes in the canonical complement system pathway. (A) Interaction and expression of canonical complement
system pathway genes in the wild type H99-infected animals. (B) Interaction and expression of canonical complement system pathway genes in
the mutant-infected animals. Shapes in red are up-regulated and the intensity of shape colors is relative to the level of gene expression (dark
color denotes stronger expression).
Liu et al. Cell Communication and Signaling 2014, 12:51 Page 11 of 17
http://www.biosignaling.com/content/12/1/51network gene expression involved in host detrimental pro-
cesses such as necrosis and cell death that are associated
with inflammation, supports our hypothesis that the host is
more tolerant to the infection by the mutant compared to
the wild type. Because of the similar in vivo growth of the
wild type and the itr1aΔ itr3cΔ mutant inside the infected
brains, the degree of difference in the host defense response
may not be enough to cause an increased killing of fungal
cells, which is consistent with our data showing a modest
prolonged survival rate of mice infected by the mutant,
compared to the wild type [18]. In the present study,
differential gene expression profile in the wild type- and
mutant-infected mouse brain is a net result of differential
expression of all the cells at the site of infection (both
resident and/or recruited during to infection). However, thenature and distribution of various immune cell populations
in the mouse brain infected by the wild type or mutant
strains and their role in differential pathogenesis are un-
known and are currently under investigation.
In our study, the exacerbated activation of neurological
diseases and cell death network genes in the brain is as-
sociated with the early death of mice infected with the
wild type strain, relative to the mutant [18]. Activation
of host cell destruction networks/pathways is corrobo-
rated by our histological observation that showed ex-
tensive disease pathology in these chronically-infected
mice brains. In contrast, infection by the mutant strain,
which is attenuated for virulence, is associated with sig-
nificantly elevated expression and activation of host
genes involved in host protective immunity networks/
Figure 7 Gene expression analysis by qRT-PCR. Expression levels of 15 host genes were measured in the wild type or the itr1aΔ itr3cΔ double
mutant-infected mouse brains. Gene expression levels are plotted as relative expression (log2) (average ± SD) in each sample, compared to the
levels in the uninfected mice brain. The expression level of each gene was normalized to the levels of endogenous Gapdh in each of the test and
control sample. Gene expression was measured three times in each of the three samples per group.
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http://www.biosignaling.com/content/12/1/51pathways. Specifically, genes involved in cell viability
and survival, proinflammatory response, cell mediated im-
munity and complement-receptor (CR) mediated phagocyt-
osis, as well as IFN-γ and TNF-α regulon network were
significantly activated in the mutant-, compared to wild
type- infected, mouse brains. During cryptococcal infection,
engagement of surface receptors, such as TLR-4, has been
reported to signal TNF-α production, activation of macro-
phages and dendritic cells as well as other immune cells
that are important not only for the early control of infec-
tion, but also essential for IFN-γ production by the T-cellsFigure 8 Capsule size and level of GXM secreted by the wild type and
wild type H99 and the itr1aΔ itr3cΔ mutant when grown in glucose or ino
size/(capsule size + cell size) in 100 cells. (B) Amount of GXM released by
*Statistically significant based on Students’ t- test (P < 0.001). Each experand establishing an effective adaptive immunity [29]. To-
gether, IFN-γ and TNF-α regulate several downstream cel-
lular networks/pathways involved in the host protective
Th-1 type immune response against infecting pathogen
[30,31]. This is evident by the increased cryptococcosis
among humans and experimental animals that are either
defective in producing these cytokines or lacking sufficient
T cells [32,33]. In fact, IFN-γ has been shown to help elim-
inate Cryptococci from the CSF [34]. In addition, mice inoc-
ulated with recombinant C. neoformans expressing murine
IFN-γ were protected from subsequent challenge with aitr1aΔ itr3cΔ mutant strain. (A) Size of capsule produced by the
sitol as carbon source. Relative capsule size was determined by capsule
fungal cells when grown in glucose or inositol as carbon source.
iment was repeated at least 3 samples in triplicate.
Figure 9 Immunohistologic analysis of wild type or itr1aΔ itr3cΔ mutant infected mouse brain. Antibody mediated immunofluorescent
staining were performed using brain sections from mouse infected with the wild type H99 or the itr1aΔ itr3cΔ mutant strain. The stained sections
were analyzed by confocal microscopy followed by 3D reconstructions of images. Tissue sections were stained for the host cell nuclei (DAPI,
blue), fungal GXM (FITC-labeled GXM antibody 18B7, Green), host GFAP (astrocyte marker, red) or host Iba-1 (macrophage/microglia marker, red).
Scale bar: 180 μm.
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http://www.biosignaling.com/content/12/1/51virulent strain [35]. Moreover, mice vaccinated with either
heat-killed Cryptococcus cells or culture filtrate antigens
showed significant T-cell-dependent delayed-type hyper-
sensitivity reaction and were better protected against subse-
quent challenge with a virulent strain [36,37]. Similar to
these studies on animal models, elevated IFN-γ levels in the
CSF, as well as administration of recombinant IFN-γ were
directly correlated with better protective response against
cryptococcal infection in humans [38]. Taken together,
these findings are consistent with and corroborated by our
gene expression analysis that showed an association be-
tween activation of the Th-1 type immune networks/path-
ways and improved host protection.
We noted significant activation of canonical complement
activation by alternative pathway, in the brains of mutant-
but not wild type-infected mice. The role of complement
system in the protection against cryptococcal infection has
been well established [21,22]. Guinea pigs depleted of com-
plement components C3-C9 prior to cryptococcal infection
showed higher mortality than the untreated animals [39].
Importantly, the outer capsule of Cryptococcus sp. has beenshown to bind with C3, a component of the alternate
complement system and activates the respective pathway
in vitro [40-42]. However, binding of C3, and thus the alter-
nating complement activation cascade, is largely dependent
on the nature and density of the capsule. Therefore, any al-
teration in the capsule content or thickness impacts the
host-pathogen interactions during cryptococcal infection
[42-44]. Since complement activation ultimately culminates
in the onset of effective host innate immune responses, we
suggest that the differential expression of genes involved in
various complement activation pathways elicited by the
wild type and the itr1aΔ itr3cΔ mutant likely contributes to
a corresponding difference in their recognition by the host
phagocytes. However, further experiments are warranted
before concluding that differences in complement mediated
phagocytosis of the wild type and mutant strains is a factor
for the differential immune response elicited by these two
strains.
To determine the molecular immunologic correlates
of altered host protective immune response in infected
mouse brain, we hypothesized that the itr1aΔ itr3cΔ
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wild type. Previously we have shown a significant differ-
ence in fungal HA and phospholipid production bet-
ween the wild type and mutant [9], which may
contribute to their differential host response during
brain infection. Since that inositol can regulate the pro-
duction of fungal capsule under conditions of abundant
inositol availability, and that the capsule can modulate
host immunity, we focused our current study on the
capsule production and structure. We analyzed the cap-
sule size and measured the secretion of GXM polysac-
charide in wild type and the itr1aΔ itr3cΔ mutant
in vitro. Polysaccharide and its release in vivo were also
detected by immunohistologic staining of mouse brain
using a GXM-specific monoclonal antibody. We ob-
served a modest reduction in the average capsule size
between these two cryptococcal strains. Importantly, the
GXM secretion was significantly reduced in the mutant,
compared to the wild type in the inositol medium, which
could contribute to the difference in respective host im-
mune responses in infected mouse brain. Capsule has
been shown to suppress the host protective immune re-
sponse [45,46]. In addition, secretion of GXM has been
shown to cause the disruption of BBB during fungal
meningitis, indicating the importance of GXM secretion
in fungal-host interaction [8]. Therefore, we propose
that the difference in cell surface structure, especially in
polysaccharide production, contribute to an altered host
response, which results in a prolonged survival of mice
infected with the mutant compared to the wild type
strain. However, at present, we cannot rule out the con-
tribution of additional fungal factors regulated by inosi-
tol to the differences in host immune responses. It is
also possible that inositol utilization by the fungal cells
may regulate the lipid composition and secretion of cer-
tain host effectors that could lead to altered host re-
sponse during CNS infection. Based on our findings, we
propose that the modest difference in the cell surface
structure observed between the wild type and the itr1aΔ
itr3cΔ mutant cells may be sufficient to tip the immune
balance yet not enough to impact the survival of the fun-
gal cells in the infected brain.
Methods
Ethics Statement
The animal studies conducted at Rutgers University were
in full compliance with all of the guidelines set forth by the
Institutional Animal Care and Use Committee (IACUC)
and in full compliance with the United States Animal
Welfare Act (Public Law 98–198). The Rutgers IACUCs
approved all of the vertebrate studies. The studies were
conducted in facilities accredited by the Association for
Assessment and Accreditation of Laboratory Animal Care
(AAALAC).Murine infection and RNA preparation
C. neoformans wild type strain and the itr1aΔ itr3cΔ
double mutant were grown at 30°C on yeast extract-
peptone-dextrose (YPD) agar medium. For animal infec-
tion, Cryptococcus cells were grown at 30°C overnight
and cultures were washed twice with 1x phosphate-
buffered saline (PBS) by centrifugation, and resuspended
at a final concentration of 2 × 105 CFU/ml. Groups of three
female A/Jcr mice (NCI-Frederick, MD) were used for each
infection. For intravenous injection model, 5 × 104 yeast
cells in 100 μl volume for each strain were inoculated via
tail vein injection. Animals that appeared moribund or in
pain were sacrificed by exposing to CO2.
Total RNAs was isolated from mouse brains that were
either infected by the wild type or the itr1aΔ itr3cΔ mu-
tant (n = 3) for 7 days. A group of 3 mice injected with
PBS buffer were used as uninfected control. Each brain
samples were processed separately for total RNA isola-
tion using Trizol reagent, treated with DNase I and purified
with RNA clean-up kit (Clontech, Mountain View, CA).
Purified total RNAs from the infected and uninfected
mouse brains were quantified using a Nanodrop spectrom-
eter (Thermo Scientific, Waltham, MA) and used in the
RNA-Seq and qRT-PCR experiments. The mRNA was
enriched by using the oligo(dT) magnetic beads and dis-
rupted to shorter fragments (about 200 bp). The first strand
cDNA was synthesized by random hexamer-primer using
the mRNA fragments as templates. The double strand
cDNA was purified with QiaQuick PCR extraction kit and
washed with EB buffer for end repair and single nucleotide
A (adenine) addition. Finally, sequencing adaptors were li-
gated to the fragments. The required fragments were gel
purified and enriched by PCR amplification. The library
products were used for sequencing analysis via Illumina
HiSeq™ 2000 at BGI (Shenzhen, China).
RNA-Seq Data analysis
The gene expression level was calculated by using RPKM
method (Reads Per Kb per Million reads) as described [47].
The log2-transformed transcript levels from uninfected,
wild type-infected or mutant-infected mice brain (n = 3 per
group) was further analyzed by Partek Genomics Suite
(Partek, St.Louis, MO) for statistical analysis and to identify
significantly differentially expressed genes (SDEG) in the
infected group, relative to the uninfected animals. The
normalized RNA-Seq data from each group (n = 3) were
averaged and analyzed by one-way ANOVA with equal
variance for significance [48]. To identify SDEG, the log2
ratio between uninfected and wild type- or the mutant-
infected transcript levels was further screened by applying
an unadjusted false discovery rate (FDR) of 5% (q value ≤
0.05). The lists of SDEG for wild type- or mutant-infected
mice brains were further used to decipher the GO and net-
work/pathway analysis.
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We used Ingenuity Pathway Analysis (IPA) program
(Ingenuity Systems, Redwood, CA) to determine the gene
ontology, biological functions, networks and pathways that
were perturbed by the SDEG from wild type- or mutant-
infected animals. Gene ontology analysis was performed by
interrogating the SDEG generated in our studies with the
IPA knowledgebase as described [48]. To improve the strin-
gency, we included only mouse database from IPA for the
network/pathway analysis. We used a z-score algorithm
from IPA to predict the biological functions that are
significantly affected by the SDEG. The z-score algo-
rithm in IPA predicts the activation status of a bio-
logical function based on the direction and pattern of
expression of member genes. A z-score of ≥ +2 indi-
cates activation, while ≤ −2 refers inhibition of a net-
work/pathway in a biological function. For regulon
analysis, we included all the interacting partners (both
directly and indirectly) of regulator genes, Ifng or Tnfa,
from the SDEG dataset. These regulon are comprised
of enriched genes that are either regulating or regu-
lated by IFN-γ or TNF-α.
qRT-PCR analysis
Purified total RNA from the infected and uninfected
mouse brains used for RNA-seq was also used as tem-
plates for cDNA synthesis for qRT-PCR assay. The qRT-
PCR experiments were performed using SYBR advantage
QPCR premix reagents (Clontech, Mountain View, CA)
in a MxPro3005P qPCR system as per the manufacturers’
instructions (Agilent Technologies, Santa Clara, CA). Ex-
pression level of Gapdh was used as control to normalize
the value across different target genes. The threshold cycle
(Ct) values for individual genes were calculated by using
MxPro Software (Agilent Technologies, Santa Clara, CA)
and the transcript abundance was calculated using the for-
mula 2ΔCt, where ΔCt refers to the change in Ct between
the target gene and Gapdh. Student’s t-test was used to
calculate the p-value significance for the differential gene
expression between infected and uninfected samples.
Measurement of capsule and GXM in Cryptococcus
C. neoformans H99 (wild type) or the itr1aΔ itr3cΔ
double mutant cells (109) were inoculated into 250-ml
Erlenmeyer flasks containing 60 ml of minimal medium
[49] supplemented with glucose or inositol as carbon
source. Fungal cells were cultivated for 7 days at 30°C
with shaking (220 rpm). Then the capsule size and cell
size was measured after India ink staining. More than
100 cells for each condition were measured each time.
The relative capsule size was calculated using the
following formula: relative capsule size (%) = 100*capsule
diameter/(cell diameter + capsule diameter). The GXM
isolation and measurement were followed the protocoldescribed by Wozniak and Levitz [50]. Each experiment
was repeated at least three times. Statistical analysis was
performed by two tailed student t-tests. P <0.001 indi-
cates statistical significance.
Immunofluorescence and confocal analysis
Brain tissue sections were fixed in formalin and embed-
ded in paraffin. After de-paraffinization, tissue sections
were cut to 20 μm and were incubated in blocking solu-
tion (5 mM EDTA, 1% fish gelatin, 1% essentially Ig-free
BSA, 2% human serum and 2% horse serum) for 3 hours
at room temperature. Tissue sections were incubated
with the primary antibody (anti-GXM, anti-GFAP, 1:100,
or anti-Iba-1, 1:400) overnight at 4°C. Samples were
washed several times with PBS at room temperature and
incubated with appropriate secondary antibodies conju-
gated to FITC or Cy3 for 1 hour at room temperature,
followed by another wash in PBS for 1 hour. Tissue
sections were then mounted using antifade reagent
with DAPI (Life Technologies, Grand Island, NY) and
the cells were examined in a A1 confocal microscope
(Nikon, Melville, NY). Antibody specificity was con-
firmed by replacing the primary antibody with a non-
specific myeloma protein of the same isotype or
non-immune serum.Additional files
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